| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania Comprehensive Cancer Center, Howard Hughes Medical Institute, Department of Medicine and Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Growth arrest and differentiation of leukemic cells by phorbol 12-myristate 13-acetate (PMA) is accompanied by p53-independent activation of p21WAF1/CIP1 and c-myc down-regulation. We show that despite p21 induction in 7 of 12 human cancer cell lines treated with PMA, growth inhibition was observed only in two cell lines (SKBr3 breast and LNCaP prostate cancer cells). Treatment of SKBr3 and LNCaP cells with PMA was followed by Raf-1 hyperphosphorylation, p21 induction, Rb hypophosphorylation, c-myc down-regulation and growth inhibition. The 10 remaining PMA-resistant cell lines were comprised of 5 that failed to induce p21 and 5 that induced p21 but had defects in steps putatively downstream of this (Rb hypophosphorylation and c-myc down-regulation). Exogenous expression and subsequent failure to down-regulate c-myc protein expression in SKBr3 and LNCaP cells was correlated with acquisition of resistance to the growth inhibitory effect of PMA. Exogenous p21 expression down-regulated c-myc protein in PMA-sensitive cancer cells. Our findings suggest that induction of p21 and down-regulation of c-myc may be necessary steps in a PMA-induced growth-inhibitory pathway in cancer cells.
1 Assistant Investigator of the Howard Hughes Medical Institute and to whom requests for reprints should be addressed, at Howard Hughes Medical Institute Research Labs, University of Pennsylvania School of Medicine, Clinic Research Building, Room 437A, 415 Curie Blvd., Philadelphia, PA 19104-6148. Fax: (215) 573-9139.
Received 3/ 7/96. Accepted 11/12/96.
This article has been cited by other articles:
![]() |
M. S. Ricci, Z. Jin, M. Dews, D. Yu, A. Thomas-Tikhonenko, D. T. Dicker, and W. S. El-Deiry Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity Mol. Cell. Biol., October 1, 2004; 24(19): 8541 - 8555. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhang and P. K. H. Chow The Effect of Megestrol Acetate on Growth of HepG2 Cells In vitro and In vivo Clin. Cancer Res., August 1, 2004; 10(15): 5226 - 5232. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Day, M. T. McCabe, X. Zhao, Y. Wang, J. N. Davis, J. Phillips, M. Von Geldern, T. Ried, M. A. KuKuruga, G. R. Cunha, et al. Rescue of Embryonic Epithelium Reveals That the Homozygous Deletion of the Retinoblastoma Gene Confers Growth Factor Independence and Immortality but Does Not Influence Epithelial Differentiation or Tissue Morphogenesis J. Biol. Chem., November 8, 2002; 277(46): 44475 - 44484. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Venkateswaran, L. H. Klotz, and N. E. Fleshner Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines Cancer Res., May 1, 2002; 62(9): 2540 - 2545. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okegawa, R.-C. Pong, Y. Li, J. M. Bergelson, A. I. Sagalowsky, and J.-T. Hsieh The Mechanism of the Growth-inhibitory Effect of Coxsackie and Adenovirus Receptor (CAR) on Human Bladder Cancer: A Functional Analysis of CAR Protein Structure Cancer Res., September 1, 2001; 61(17): 6592 - 6600. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Blagosklonny and A. B. Pardee Exploiting Cancer Cell Cycling for Selective Protection of Normal Cells Cancer Res., June 1, 2001; 61(11): 4301 - 4305. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sumitomo, R. Shen, J. S. Goldberg, J. Dai, D. Navarro, and D. M. Nanus Neutral Endopeptidase Promotes Phorbol Ester-induced Apoptosis in Prostate Cancer Cells by Inhibiting Neuropeptide-induced Protein Kinase C {{delta}} Degradation Cancer Res., December 1, 2000; 60(23): 6590 - 6596. [Abstract] [Full Text] |
||||
![]() |
K. Salnikow, M. Costa, W. D. Figg, and M. V. Blagosklonny Hyperinducibility of Hypoxia-responsive Genes without p53/p21-dependent Checkpoint in Aggressive Prostate Cancer Cancer Res., October 1, 2000; 60(20): 5630 - 5634. [Abstract] [Full Text] |
||||
![]() |
C. Shelly, L. Petruzzelli, and R. Herrera K562 Cells Resistant to Phorbol 12-Myristate 13-acetate-induced Growth Arrest: Dissociation of Mitogen-activated Protein Kinase Activation and Egr-1 Expression from Megakaryocyte Differentiation Cell Growth Differ., September 1, 2000; 11(9): 501 - 506. [Abstract] [Full Text] |
||||
![]() |
T. Okegawa, Y. Li, R.-C. Pong, J. M. Bergelson, J. Zhou, and J.-T. Hsieh The Dual Impact of Coxsackie and Adenovirus Receptor Expression on Human Prostate Cancer Gene Therapy Cancer Res., September 1, 2000; 60(18): 5031 - 5036. [Abstract] [Full Text] |
||||
![]() |
K. Detjen, F. Brembeck, M Welzel, A Kaiser, H Haller, B Wiedenmann, and S Rosewicz Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest J. Cell Sci., January 9, 2000; 113(17): 3025 - 3035. [Abstract] [PDF] |
||||
![]() |
J.-S. Park, S. Boyer, K. Mitchell, D. Gilfor, M. Birrer, G. Darlington, W. El Deiry, G. L. Firestone, K. Munger, V. Band, et al. Expression of Human Papilloma Virus E7 Protein Causes Apoptosis and Inhibits DNA Synthesis in Primary Hepatocytes via Increased Expression of p21Cip-1/WAF1/MDA6 J. Biol. Chem., January 7, 2000; 275(1): 18 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O. Mitchell and W. S. El-Deiry Overexpression of c-Myc Inhibits p21WAF1/CIP1 Expression and Induces S-Phase Entry in 12-O-Tetradecanoylphorbol-13-acetate (TPA)-sensitive Human Cancer Cells Cell Growth Differ., April 1, 1999; 10(4): 223 - 230. [Abstract] [Full Text] |
||||
![]() |
X. Zhao, J. E. Gschwend, C. T. Powell, R. G. Foster, K. C. Day, and M. L. Day Retinoblastoma Protein-dependent Growth Signal Conflict and Caspase Activity Are Required for Protein Kinase C-signaled Apoptosis of Prostate Epithelial Cells J. Biol. Chem., September 5, 1997; 272(36): 22751 - 22757. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |